Boehringer Ingelheim said getting answers to the Food and Drug Administration's questions would be so much work, the task would hurt the prospects of other medicines in the company's pipeline.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/10/08/130429754/german-drugmaker-abandons-female-viagra?ft=1&f=103537970
Posted
Oct 08 2010, 01:12 AM
by
NPR Blogs: Shots - Health News Blog